These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 6313141)
21. Valbenazine granted breakthrough drug status for treating tardive dyskinesia. Müller T Expert Opin Investig Drugs; 2015 Jun; 24(6):737-42. PubMed ID: 25809133 [TBL] [Abstract][Full Text] [Related]
22. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management. Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037 [TBL] [Abstract][Full Text] [Related]
23. [Identification and evaluation of properties of benzodiazepine receptors of glial and neuronal fractions of human cerebral cortex]. Zlobina GP; Chekalina ND; Oifa AI; Mukhin AG Biull Eksp Biol Med; 1982 Oct; 94(10):51-4. PubMed ID: 6293610 [No Abstract] [Full Text] [Related]
25. Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia. McCormick SE; Stoessl AJ Neuroscience; 2003; 119(2):547-55. PubMed ID: 12770567 [TBL] [Abstract][Full Text] [Related]
26. Glycoprotein properties of benzodiazepine receptors from calf cerebral cortex. Sherman-Gold R; Dudai Y J Neurosci Res; 1983; 10(1):27-33. PubMed ID: 6310136 [TBL] [Abstract][Full Text] [Related]
32. Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. Lew TY; Tollefson G Biol Psychiatry; 1983 Dec; 18(12):1441-6. PubMed ID: 6661471 [TBL] [Abstract][Full Text] [Related]
33. Diazepam in the treatment of extrapyramidal symptoms: a case report. Director KL; Muniz CE J Clin Psychiatry; 1982 Apr; 43(4):160-1. PubMed ID: 6121790 [TBL] [Abstract][Full Text] [Related]
34. Midification of tardive dyskinesia and spasmodic torticollis by apomorphine. Possible role of dopamine autoreceptors. Tolosa ES Arch Neurol; 1978 Jul; 35(7):459-62. PubMed ID: 666598 [TBL] [Abstract][Full Text] [Related]
36. Cholinergic influences in tardive dyskinesia. Tamminga CA; Smith RC; Ericksen SE; Chang S; Davis JM Am J Psychiatry; 1977 Jul; 134(7):769-74. PubMed ID: 869054 [TBL] [Abstract][Full Text] [Related]
37. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. Bai YM; Yu SC; Lin CC J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949 [TBL] [Abstract][Full Text] [Related]
38. Case report of adverse effect of reserpine on tardive dyskinesia. Donatelli A; Geisen L; Feuer E Am J Psychiatry; 1983 Feb; 140(2):239-40. PubMed ID: 6129810 [TBL] [Abstract][Full Text] [Related]
39. Treatment of tardive dyskinesia with bromocriptine. A test of the receptor modification strategy. Lieberman JA; Alvir J; Mukherjee S; Kane JM Arch Gen Psychiatry; 1989 Oct; 46(10):908-13. PubMed ID: 2572205 [TBL] [Abstract][Full Text] [Related]